Dr Ngashi Ngongo

A new and potentially more infectious variant of mpox Clade 1A has been identified in the Democratic Republic of the Congo (DRC) according to Dr Ngashi Ngongo, head of the mpox incident management team at the Africa Centre for Disease Control and Prevention (Africa CDC).

The termination of USAID funding and violence in eastern DRC are hampering mpox testing and reporting, with test results being reduced to a trickle.

Only 35% of mpox cases are currently being tested in DRC, both because of conflict and the ending of USAID funds to transport mpox tests to laboratories.

 

The DRC finally started to vaccinate people in Kinshasa this week, and uptake was swift with over 24,800 people vaccinated over four days, said Ngongo.

Mpox is continuing to spread in Uganda, which has seen case increases for three weeks in a row ​​– 278 new cases in the past week.  Mpox cases are overwhelming health facilities. For example, a treatment centre in Entebbe with 80-bed capacity currently has 102 patients.

“Because of this, the leadership in the [Ugandan] Ministry of Health has now opted also to introduce home-based care for non-severe cases,” said Ngongo.

Meanwhile, South Africa reported three mpox cases after being free of the disease for over 90 days.

The World Health Organization resolved this week to keep mpox as a public health outbreak of international concern “based on the continuing rise in numbers and geographic spread, the violence in the eastern DRC, which hampers the response, as well as a lack of funding to implement the response plan”, according to the WHO.

Febrile disease in DRC

DRC health authorities are investigating a febrile disease outbreak in five villages in the Basankusu and Bolomba health zones in Equateur province. This has tripled deaths over the past three weeks, according to WHO.

A total of 943 cases and, 52 deaths have been reported, with symptoms including fever, chills, sweating, headache and muscle pain.\, said Ngongo.

There are no haemorrhagic symptoms and Ebola and Marburg tests are negative, making malaria the most likely cause, he added.

“Children below five years make about 18% of cases with a case fatality of 5.3%. Children ages five to 15 years make up 20% of all cases, with a case fatality of 6.4%,” said Ngongo.

“The diagnostic is pointing towards malaria. Rapid tests that were conducted on over 500 samples gave a positivity rate of 55% but there are also blood smears that were also conducted, around 70 samples, that also gave a positivity rate of almost 78%,” said Ngongo.

“Further tests are to be carried out for meningitis. Food, water and environmental samples will also be analysed, to determine if there might be contamination,” according to the WHO.

“Basankusu and Bolomba are about 180 kilometres apart and more than 300 kilometres from the provincial capital, Mbandaka. The two localities are reachable by road or via the Congo River from Mbandaka. This remoteness limits access to health care, including testing and treatment. Poor road and telecommunication infrastructure are also major challenges,” saif the WHO in a statement.

Protestors gathered outside USAID headquarters in Washington D.C. after employees were informed via email to not come in to work.

The Trump administration has terminated the contracts of nearly 10,000 global health projects funded by the US Agency for International Development (USAID) or the US State Department  – including projects to provide vital diagnosis and treatment for HIV, tuberculosis, and malaria, as well as humanitarian aid projects providing nutrition and water and sanitation services.

Grants to hundreds of African HIV organisations providing life-saving services have been terminated with immediate effect via letters received on Thursday morning.  Globally, the terminated awards include 5,800 grants administered by the USAID and 4,100 grants for projects managed directly by the State Department. Some of the terminated programmes had previously been granted temporary waivers, due to their roles in providing lifesaving health or humanitarian aid.

The Trump administration also announced Thursday that it was halting US funding to the Joint UN Programme on HIV/AIDS (UNAIDS), which is headquartered in Geneva, just across from the World Health Organization.

“All malaria supplies protecting 53 million people, mostly children, including bed nets, diagnostics, preventive drugs, and treatments – terminated,” said Dr Atul Gawande, USAID’s former assistant administrator under the Biden administration.

Terminated, too, are all global tuberculosis programmes, all US-made food aid programmes, which manufacture specially enriched foods aimed at malnourished women and children, and around 1000 food kitchens serving displaced people in countries such as war-torn Sudan.

“This is one of the worst days of my professional life,” said Dr Kate Rees of Anova Health Institute in South Africa, which delivers HIV services to hard-to-reach groups. “Tomorrow, we are letting go 2,800 people who are mainly peer educators and data capturers.”

Prof Linda-Gail Bekker, CEO of the South African Desmond Tutu HIV Foundation, said that the US termination would cost 500,000 South African lives over the next 10 years and result in around half a million new HIV infections, according to recent modelling.

“As an activist, as a person living openly with HIV, I’m very hurt,” said  Sibongile Tshabalala, chairperson of the Treatment Action Campaign. “How am I going to survive? Will the public health care system be able to cater for us? Will be able to cover all the gaps that we are facing with all the challenges that the public healthcare system has?”

South Africa has the highest burden of HIV in the world with eight million people living with the virus (over 16% of the adult population).

All 44 South African HIV programmes that receive money from the US President’s Emergency Plan for AIDS Relief (PEPFAR) through USAID have seen their aid terminated. Projects affected range from mother-to-child transmission programmes and hospices to research groups. Many focus on “key populations”, groups that are the most vulnerable to HIV but often shun health centres in fear of discrimination.

“I’ve been having a sleepless night trying to think how best we can save our communities because we know that some of the government healthy facilities are very discriminatory,” said Kholi Buthelezi, national coordinator of the sex worker organisation, Sisonke.

HIV activist Sibongile Tshabalala, who lives with the virus, is fearful for her future.

HIV programmes devastated across Africa

HIV programmes across the continent have also been devastated. The Elizabeth Glaser Paediatric AIDS Foundation (EGPAF) was told to close programmes in Lesotho, Eswatini and Tanzania that cover HIV treatment for 350,000 people including almost 10,000 children.

In Uganda, for example, the Baylor College of Medicine Children’s Foundation’s HIV and TB programmes, that strengthens district health systems to better deliver HIV, TB and maternal and child services, has been terminated.

The termination letters all state that US Secretary of State Marco Rubio, in his capacity as acting administrator for USAID and Peter Marocco, USAID acting deputy administrator, “have determined your award is not aligned with agency priorities and made a determination that continuing this program is not in the national interest”.

‘Chaos and disaster’

The terminations have caused “chaos” and “disaster”, said emotional South African leaders of the HIV sector who urged their government to step in to save their programmes.

Fatima Hassan, head of the Health Justice Initiative, urged the South African government to issue compulsory licenses to reduce the price of antiretroviral medicine as the US has already “done the worst to us”.

“US Congress approved the funds, and that is what has been stopped. So we do believe that it’s an illegal grab. It’s an illegal halt of services and programs. It’s not following due process,” Hassan added.

The terminations will decimate South Africa’s HIV testing, data collection and HIV and TB literacy, said public health expert Dr Lynne Wilkinson, who added that USAID funds also assisted groups combating gender-based violence.

However, South Africa is luckier than many other African countries as it derives around 17% of its HIV budget from PEPFAR. The Democratic Republic of Congo (DRC) gets 89% of its HIV budget from PEPFAR, while Mozambique and Tanzania get 60% of their HIV budget from the US.

USAID: Countries most reliant on US aid for HIV

‘Blanket freeze is illegal’

Mitchell Warren, head of the US-based HIV programme AVAC, described the blanket termination of USAID grants as “unlawful”.

“The US government’s in a very strong position with any cooperative agreement or grant or contract. They’re allowed to cancel agreements or amend them. They’re in a very strong position generally, but the blanket freeze is illegal,” said Warren, whose organisation has resorted to the courts to prevent the cutting of lifesaving aid.

AVAC’s Mitchell Warren

“We have been now in a federal court for several weeks, and a temporary restraining order was provided two weeks ago by the Court that said that things had to go back. The tap had to be put back on until this 90 day review actually took place in a comprehensive way,” he added.

“We now have evidence entered into the public record in the courts that show the intentionality at USAID and the State Department to dismantle everything but the government has simply thrown up additional legal delays, as is their want,” said Warren.

A federal judge had set Wednesday at midnight as the deadline for USAID to release some $1,5 billion funds for the foreign aid work already completed, but the US Supreme Court granted the government a stay on the release of funds until the court could apply itself more thoroughly to the issue.

“We expect a hearing next week in Washington,” said Warren.

“This is not about PEPFAR. This is not about the HIV response. This is not about USAID. This is about the rule of law.  The United States Congress has the power of the purse. They decide what gets spent. The executive branch is there to execute, and that’s the basis of this legal argument.

“But as of [Wednesday] night, they began to basically massacre every possible implementing agency to deliver on this work. This court case, as important as it is, is not going to change that overnight. That’s why working in partnership with each other and with national governments is essential because the United States is not a partner that is trustworthy  right now,” Warren concluded.

Image Credits: Reuters Youtube, Gandhi A, et al, Annals of Internal Medicine, 11 Feb. 2025, UNAIDS.

Marie Grace Pendo needed a mechanical valve for her heart when she was nine years old.

KIGALI, Rwanda – When Marie Grace Pendo was nine years old, she flew from Rwanda to India with a group of other patients and her doctor to have a mechanical valve implanted in her heart.

Pendo had rheumatic heart disease, usually caused by an untreated bacterial infection. She had little energy and her life was in danger. With only one cardiologist in Rwanda at the time – 2016 – she had little chance of receiving the life-saving operation. The Rwandan government paid for her travel and operation in India.

Pendo, now aged 20, tells Health Policy Watch that she is on blood thinners for life but other than that, lives a normal life under the care of health workers at Masaka District Hospital.

If she needed the operation now, she could stay in the country as Rwanda is slowly producing more cardiologists. There are currently six, with four more due to graduate within months.

Dr Everiste Ntaganda, director of cardiovascular disease at the Masaka Hospital, says Pendo’s medication and monthly consultations are covered by the country’s compulsory Community-Based Health Insurance (CBHI), introduced in Rwanda in 2004 as part of the country’s rollout of universal access to healthcare (UHC).

In 2003, only 7% of people had health insurance but currently, over 80% of the country’s 14 million citizens are part of the  CBHI, the highest universal health coverage rate of any low-income country (LIC).

The CBHI is funded by members’ premiums, taxes, and donor funding. Premiums are based on people’s income with people divided into six categories, paying zero (Category 1) to around $6 a year. Most people pay around $2 annually in Rwanda, which derives its main income from agriculture. 

Not all treatments are covered by the CBHI but the country is adding to what is available each year and treatment for breast cancer has been included for the first time this year. Rwandans are expected to pay 10% of the cost for treatments and medicines that are not covered – but that lies way beyond the reach of most people. In the poorest cases, the government endeavours to shoulder the entire cost.

Reorganisation of health services

When Paul Kagame came to power in 1994 after the genocide in which approximately one million people were killed, he made health a key pillar of rebuilding the country.

Rwanda- decentralisation of NCD care

From a highly centralised system, the country has decentralised its health services, including the management of non-communicable diseases (NCDs), to reach more people closer to their homes to minimise transport costs.

Masaka is in the midst of a huge Chinese-enabled revamp that will almost triple its beds and, once completed it will become a teaching hospital.

The hospital caters for half a million people and its focus is on NCDs, said Dr Jean Damascene Hanyurwimfura, the hospital’s Director-General, pointing to the 2023 statistics which show 46% of deaths in facilities and 61% in communities are NCD-related.

“We decentralised because we can’t keep treating everyone at the hospital,” explains Dr Francois Uwinkindi, manager of NCDs at the Rwanda Biomedical Centre, which is the implementation arm of the health ministry.

Dr Francois Uwinkindi, head of NCDs at the Rwanda Biomedical Centre

“Before this, people could also spend $20 on transport which was higher than the cost of their healthcare.”

Rwanda has focused on NCD prevention and succeeded in reducing tobacco consumption, almost halving its use from 13% of the population in 2012 to 7%, said Uwinkindi.

But it hasn’t been able to reduce alcohol consumption, which has increased from 41% in 2012 to 48%. Hypertension and obesity are also up, although these are still a modest 17% and 4% respectively as the vast majority of the agrarian population gets enough exercise through their work. 

Rwanda’s capital city, Kigali, holds monthly car-free Sundays that not only prohibit vehicles in certain areas but are designed to encourage physical activity. Screenings for NCDs include diabetes and hypertension are also offered at some of the car-free days.

Community health workers in every village

The base of the country’s decentralised health services rests squarely on the shoulders of over 58,000 community health workers (CHW). These CHW are elected by village and town meetings, positions that mostly appeal to older residents. 

Each village elects four CHW who are allocated around 60 households to interact with.

Like in most African countries, the CHW are volunteers – but when budget allows, they get a little performance-related stipend, says Emery Hezazira, who heads the country’s CHW programme.

They need to be over the age of 21 and have completed primary school with good literacy and numeracy skills, as well as holding the trust of their communities, according to a health ministry document.

The document lists the CHW’s 15 tasks including diagnosing and managing malaria and tuberculosis cases, providing basic maternal and child care, managing childhood illnesses and conducting awareness campaigns about mental health and behavioural disorders.

They encourage behaviour to prevent NCDs, promote nutrition and promote HIV awareness.

“There is no fixed remuneration, CHWs receive their community performance-based financing (CPBF) on quarterly basis. The CPBF depends on the performed priority indicator, available funds, weight and unit cost of each indicator,” according to the document.

The CHWs are supervised and managed by the health centres, essentially primary healthcare clinics. The health centres are managed by district hospitals.

About 1000 CHW are active around Masaka, and they help to drive prevention messages, according to Uwinkindi.

During the recent Marburg outbreak, they went door-to-door in affected communities encouraging anyone with a fever and symptoms to go to their closest health facility.

In future, the health authorities want ongoing community awareness and education about NCDs and CHW to do more NCD screening. But as demands on CHW grow, so too may pressure to pay them –  challenge faced by all African countries that have introduced CHW.

Elderly women with alzheimer's sit together
A group of older women socialise at Ukingu village in Geita region, with Hadija Kisanji on the far right.

GEITA, Tanzania —The first time 78-year-old Hadija Kisanji got lost on her way home, neighbors found her sitting under a baobab tree, staring blankly at the dusty road. When they asked where she was going, she whispered, “I think I live nearby.” That was three years ago. Today, Kisanji barely remembers her own name.

She’s amongst the many elderly Tanzanians silently battling dementia—a condition often mistaken for witchcraft. In a country where mental illness is stigmatized, dementia is not just an illness—it is a slow erasure of identity, leaving families struggling in isolation.

A life fading away

Alzheimer's dementia tanzania
Hadija Kisanji, 78, who suffers from dementia sits with her daughter Mariam and grandchildren.

Kisanji’s daughter, Mariam, has watched helplessly as her mother plunges further into confusion. “She calls me ‘mother’ sometimes,” Mariam told Health Policy Watch. “She doesn’t remember I am her child. She asks if her parents are coming back, but they’ve been dead for 50 years.”

In rural Tanzania, where medical facilities are scarce, dementia and Alzheimer’s remain largely undiagnosed. Families struggle to manage symptoms – wandering, memory loss, aggression – without professional guidance. “Some believe that when old people start acting strangely, they are bewitched,” said Mfaume Kibwana, Chief Medical Officer at  Geita Regional Referral Hospital. “It’s heartbreaking because dementia is a disease, not a curse to dispel. Yet many remain blinded by mistaken beliefs in witchcraft, and changing their minds isn’t easy.”

For Kisanji, the disease has turned her life into a puzzle of lost time. Once a respected midwife, she now spends her days clutching a stuffed teddy bear, convinced it is her real baby. “Shhh, don’t wake him,” she whispered to this reporter, holding the doll firmly in her frail arms.

A town struggling to understand

Geita, a region in northwestern Tanzania, near the southern shores of Lake Victoria and the Rwandan border.

Geita, a gold-mining region in north-western in Tanzania, near the Rwandan border and the shores of Lake Victoria, lacks specialized dementia care. The few health centres available are overstretched. Many families never seek medical attention, assuming dementia is a natural part of aging or fearing social stigma.

Even when families try to access care, the costs are prohibitive. “The doctor said my father needs special medicine,” says Juma Magesa, whose 82-year-old father, Mzee Rashid, was diagnosed with Alzheimer’s. “But where do I get 200,000 shillings ($80) every month when I can hardly feed my children?”

Magesa has resorted to tying a small bell to his father’s wrist. “At night, he tries to leave the house. If I hear the bell, I wake up and stop him.”

Social isolation worsens the situation. “People stopped visiting us,” says Rehema Komba, who takes care of her 89-year-old mother Joseline Kombe. “They say she is bewitched. Even my own relatives tell me to take her to a witch doctor instead of a hospital.”

A glimpse across Africa

Alzheimer's in Africa
Joseline Kombe, 89, (on right) sits with relatives who are weaving baskets.

The struggle of dementia patients in Tanzania reflects a broader crisis across Africa, where ageing populations are rising but geriatric healthcare remains underdeveloped. The World Health Organization estimates that by 2050, nearly 10% of Africa’s population will be over 60.

Dementia is already on the rise in Sub-Saharan Africa, with 2.13 million people affected in 2015—a figure projected to soar to 7.62 million by 2050.

A daring thief of memory and autonomy, dementia now affects over 55 million individuals globally, with nearly 10 million new cases emerging each year. Alarmingly, more than 60% of those living with dementia reside in low- and middle-income countries, where resources for care and support are often scarce. 

The economic toll of dementia is staggering. In 2019, the global cost was estimated at US$1.3 trillion, a figure projected to rise to US$1.7 trillion by 2030, and potentially US$2.8 trillion when accounting for increases in care costs. Informal caregivers, often family members, shoulder approximately half of these expenses, dedicating an average of five hours daily to care and supervision. 

People living with dementia could triple by 2050

Beyond the financial strain, dementia casts a profound shadow on human lives. It is currently the seventh leading cause of death worldwide and a major contributor to disability and dependency amongst older adults. Women are disproportionately affected, both as patients and caregivers; they account for 70% of care hours provided to those living with dementia. 

As the global population ages, projections indicate that the number of people living with dementia could triple by 2050, reaching 152 million. This looming crisis underscores the urgent need for comprehensive public health strategies, increased awareness, and robust support systems to address the multifaceted challenges posed by dementia. 

The World Health Organization’s member states recognized dementia as a public health priority in 2017, endorsing a Global Action Plan (2017-2025), due to come up for review at this year’s May World Health Assembly. This plan provides a comprehensive blueprint for action across seven strategic areas, including increasing awareness, reducing risk, and providing support for caregivers. 

But the growing burden of dementia also highlights potential opportunities for the African continent to innovate and develop interventions. Experts convening in Nairobi at last year’s inaugural Nature conference on brain health and dementia noted that researchers could gain valuable insights into risk factors through the study of Africa’s very diverse populations, leading to the development of more effective as well as affordable interventions for dementia worldwide. 

“With 80% of the people with dementia likely to be in the Global South by 2050, it’s imperative that we bring the high-resource communities and the Global South together to solve the problem,” said George Vradenburg, founder of the Davos Alzheimer’s Collaborative, which co-sponsored the event.

The burden of care

In many or most African households, caregiving typically falls on the shoulders of women—daughters, granddaughters, or wives. 

Mariam, for instance, quit her job as a teacher to care for her mother full-time. “It is like watching a candle burn out,” she says. “One day, she knows who I am. The next, she doesn’t even recognize her own face in the mirror.”

With no nursing homes or hospice care, families rely on each other. “I can’t leave her alone,” Mariam says. “She might wander into the street. She might fall into the fire while cooking.”

Dr Kibwana warned that caregivers, too, suffer silently. “They develop anxiety, depression, even physical health problems from stress. But they don’t talk about it because, in our culture, taking care of your parents is a duty, not a choice.”

A mother forgotten

Alzheimer's elderly Tanzania dementia
Rehema Magesa, 81, walks outside her house in Geita. She doesn’t remember her name.

 An old woman sat on a wooden stool outside a crumbling mud-brick house, her faded khanga wrapped tightly around her frail shoulders. Her eyes, clouded with confusion, darted back and forth, as if searching for something just beyond reach. The late afternoon sun bathed her wrinkled face in gold, but there was no warmth in her expression – just an emptiness that had swallowed the person she used to be.

Her name is Rehema Magesa, or at least that’s what her family tells her. She does not remember. At 81, Alzheimer’s and dementia have stolen the sharp-witted woman who once ran a thriving fish stall at the Mwanza market, and raised six children with the strength of a lioness. Now, she barely recognizes them. She calls her eldest son “Baba” and mistakes her teenage granddaughter for the neighbor’s child. Some days, she accuses her own family of stealing her money – money she hasn’t earned in years.

Inside the house, her daughter Halima stirs a pot of thin maize porridge, her face drawn with exhaustion. “She wakes up at night and wanders,” Halima said, glancing toward the door, as if fearing her mother might slip out again. “Last week, we found her on the road to the lake, barefoot, shivering. A stranger had to bring her home.” There’s no money for a caretaker, no proper medication, no respite. The family struggles to make ends meet, and Magesa – once the pillar of the household – has become its heaviest burden.

At dusk, she sits quietly, tracing invisible patterns in the dust with her fingers. Her son, Rashid, watches from a distance. “She carried me on her back when I was a baby,” he said. “Now, she doesn’t even know who I am.”

Fighting a ‘big war with small weapons’ 

Healthcare in Tanzania
Caption Dr. Wilfred Chuwa of Bugando Regional Referral Hospital, attending to a patient in Mwanza.

Tanzania’s healthcare system has made progress, but dementia care remains overlooked in national policy. There are no awareness campaigns, no government-funded housing for older people, and no formal support networks for caregivers, leaving families to navigate the challenges alone.

Experts warn that dementia cases will rise sharply as the country’s ageing population grows. “We are sitting on a time bomb,” said Dr Kibwana. “If we do nothing, thousands of elderly people will suffer in silence, and families will continue to bear a heavy burden.”

Some grass roots organizations are trying to fill the gap. A local NGO in the port-city of Dar es Salaam , The Good Samaritan Social Service Tanzania, has started training community health workers to identify and recognize dementia symptoms. “We go door to door, talking to families,” said volunteer Neema Kijazi. “We tell them, ‘Your mother is not possessed. She is sick.’”

But resources are limited. “We need more training, more medicine, more doctors,” Kijazi said. “Right now, we are fighting a big war with small weapons.”

Ageing in poverty

Dementia care is just one part of a larger crisis facing Tanzania’s elderly. In a country where more than half the population is under 18, older people are often overlooked. Life expectancy remains low—68.4 years for women and 65.2 for men—but those who surpass this threshold face a brutal reality, where survival is a daily battle.

“Our bodies are fragile. As  we grow old, our strength and vitality diminish while ill health set in with a devastating impact,”said Zena Mabeyo professor of social welfare at the Institute of Social Work in Dar Es Salaam.

But for most people she knows, retirement is a foreign concept. Nearly 96% of older Tanzanians keep working out of necessity, tending small farms, selling vegetables, or weaving mats. The fortunate ones own a few goats or chickens—their version of a “bank account.”

“Diminishing strength and stamina obviously affects the kind of work that elderly people can do and how long they can do it,” Mabeyo told Health Policy Watch.

Those too frail to work rely entirely on their families’ support. Tanzania has no universal pension system, and only former government employees receive stipends – although too small to sustain them.

The gradual breakdown of both traditional and modern support systems has left many elderly Tanzanians struggling to survive.

Although the country has recognized ageing in its national policy, this is a largely rhetorical gesture, critics say. Policies fail to effectively address the needs of older people, and particularly those suffering from dementia and Alzheimer’s.

“We haven’t seen meaningful interventions for older people with dementia and Alzheimer’s in Tanzania,” Mabeyo said. “Without a clear strategy for diagnosis, care, and support, many elderly people continue to suffer in silence.”

Prioritizing dementia in Africa

Alzheimer's aging elderly Tanzania
Maria Maserere, another local resident with dementia, sits outside her home in Gaita’s rural environs.

Public health experts like Dr Kibwana urge Tanzania and other African nations to prioritize dementia as a public health issue. They stress the need for awareness campaigns, caregiver support programs, and affordable medication. Without these measures, they warn, thousands of families will continue to struggle alone, and the silent suffering of the elderly will only worsen.

For now, Mariam and many others remain trapped in a cycle of care and grief, hoping for a future where their loved ones can live with dignity, not in the shadows.

Each day is a battle against the unknown. “I don’t know how long I can do this,” she admits. “I pray that one day, someone will help us.”

Juma echoes her fears. “We are drowning,” he says. “Nobody sees us, nobody hears us.”

As the darkness sets in Geita, Kisanji sits on the squeaking wooden bench, humming an old Sukuma(tribe) lullaby. For a brief moment, she looks at Mariam and smiles. “Mama,” she says softly.

Mariam squeezes her mother’s hand, holding onto that fleeting moment of clarity. Because tomorrow, Kisanji may forget again. And all Mariam can do is wait – and remember for both of them.

Image Credits: Kizito Makoye Shigela/HPW, Google Maps , Kizito Makoye Shigela/HPW, Muhidin Michuzi.

Encephalitis, the inflammation of the brain, can cause long-term damage. Its current global burden is unknown.

Encephalitis “remains under-recognized, under-diagnosed, and underfunded”,  according to a new policy report from the World Health Organization (WHO).

Climate change, vaccine hesitancy, and the rising burden of vector-borne diseases are also fuelling an increased number of encephalitis cases, a rare but serious inflammation of the brain. 

The technical document urges coordinated global action to “confront and tackle the growing public health threat from encephalitis,” and points to prevention strategies, as well as gaps in diagnosis, research, treatment, and care. 

“Unless prompt action is taken, encephalitis will continue to drive avoidable deaths and disability,” notes Encephalitis International, a global advocacy non-profit.

“Regrettably, the withdrawal of support for the WHO and potential dissolution of USAID by President Donald J Trump’s Administration, among other recent executive actions, threaten to worsen an already challenging situation,” said the non-profit in a statement.

The report comes as measles, which in some cases can cause encephalitis ,continues to plague higher-income countries, including a recent outbreak in West Texas, where a “close-knit, undervaccinated” Mennonite community is at the epicentre of a 58-person outbreak.

Vaccine skeptics received a strong boost in the confirmation of Robert F Kennedy Jr as Secretary of the Department of Health and Human Services. The Secretary spent more than 30 years sowing doubt as to the safety of vaccines. Measles, mumps, and rubella–diseases prevented by routine childhood vaccines–can also in some cases cause encephalitis. 

‘Life-threatening’ brain inflammation

Encephalitis, the swelling of the brain, affects people across all age groups, and has high mortality rates. 

“Unlike other organs or organ systems, the brain is very sensitive to swelling and inflammation…when the brain is injured, it can have permanent effects on the brain’s function – like walking, talking, even causing seizures,” said Dr Youssef Kousa, a neurologist and founder of the Zika Genetics Consortium at Children’s National Hospital, in an interview with Health Policy Watch.

“For a lot of encephalitdes, there are no treatments.”

The condition often leads to significant long-term complications including hearing loss, seizures, limb weakness, and difficulties with vision, speech, language, memory and communication, according to the WHO.

Globally in 2021, encephalitis was the fourth leading cause of neurological health loss in children under five years and the 13th across all age groups. The report notes that in the same year, over 80,000 people died from encephalitis and up to 50% of people with encephalitis suffered long-term after-effects of the condition, losing “independence, income and quality of life.”

Underdiagnosed and lacking political commitment

Encephalitis mortality map
Mortality from encephalitis is the highest in South and South-East Asia, where Japanese Encephalitis Virus is likely to continue spreading.

“Encephalitis is a growing public health challenge, and by prioritizing it within global and national health agendas and strengthening collaboration, we can reduce its impact and save lives,” said Dr Tarun Dua, head of the Brain Health Unit at the WHO, in a press release. 

“These efforts will not only improve health outcomes and quality of life for those affected and their families but also result in stronger, more resilient health systems.” The Brain Health Unit at WHO was only formed in 2020, as a growing number of brain-related conditions affect both lower and higher income countries, notably Alzheimer’s, Parkinson’s, epilepsy, and encephalitis. 

“I sit here just as Oropouche virus is increasing in cases in South America, right now and as yet, barely studied. Without surveillance, this virus will continue to spread almost unnoticed,” said Dr Aline MB Matos, a neurologist from São Paulo, Brazil, at the report’s launch on Wednesday.

“Encephalitis today is not a funding priority in many low and middle income countries, not because it is not important, but because these countries face multiple crises. Lack of clean water, limited access to education, an overburdened healthcare system, armed conflicts. And as a reality, it is difficult to choose what to prioritize.

“But encephalitis must be a priority.”

Diagnosis in lower-and-middle income countries is especially difficult, because the condition requires a confirmatory lumbar puncture, and sometimes highly specialized tests such as brain imaging and electroencephalography (EEG). However, as the report notes, and as Matos highlighted in her remarks, most of the world’s population lives in areas with no immediate access to comprehensive or rapid encephalitis diagnostics. 

“In many countries, lumbar punctures are performed on only some of the people with suspected brain infections. This may be due to a lack of trained workforce or procedural kits, and misconceptions about lumbar puncture indications and safety,” noted the report. 

But even in higher-income countries, there are only so many treatments for the viruses that cause encephalitis, said Kousa. Even if Zika or West Nile Virus can be diagnosed more readily in the US, providers have nearly the same limited treatment options as those in lower-income countries. 

Vector-borne diseases pose new threat 

Although JEV is rare, the mosquito-borne disease can have a case-fatality rate as high as 30%.

Several pathogens can cause encephalitis, with the herpes simplex virus being the most common cause of the condition, according to the WHO. But other viruses, notably vector-borne diseases, are a rising threat for encephalitis. 

Dengue, Zika virus, and oropouche virus are all increasing in incidence and prevalence in South America, the Caribbean, and South and South-East Asia, as warming climates, deforestation, and urbanization spur mosquitoes into closer proximity to humans. Almost half of the global population is now at risk for these diseases.

Recent dengue outbreaks have plagued the Indian subcontinent, and oropouche virus, a relatively rare vector-borne disease, is likely to see case levels similar to last year’s record-breaking season.

Also of concern is Japanese Encephalitis virus (JEV), which has now spread to 24 South-East Asia and Western Pacific countries, including Australia, and a novel tick-borne encephalitis. 

“We do not know the full number of encephalitis cases worldwide, but we do know that infectious causes play a major role, and in low and middle income countries, many of these pathogens are either emerging or being neglected,” said Matos. The problem is only exacerbated by climate change, as previously uninhabitable regions become mosquito breeding grounds. 

“This renders large populations at increasing risk of vector-borne diseases such as arboviruses,” noted the report.

While these diseases have few – or even no – vaccines, some more established, and vaccine-preventable diseases, are seeing a resurgence.

Encephalitis-inducing viruses can be prevented by vaccines, such as influenza, varicella-zoster virus (VZV), rabies, poliomyelitis, and measles, mumps and rubella (MMR). The COVID-19 pandemic-related disruptions in routine immunizations and vaccine hesitancy have left experts worried about encephalitis cases due to MMR. 

“Vaccine hesitancy is an issue for us, and it’s part of this bigger picture science skepticism and false information. So it’s up to us as a community to push out the right messages,” said Dr Tom Solomon CBE, a neurologist at Liverpool University Brain Infections Group, at the report launch. Solomon is also President of Encephalitis International and an advisor to the WHO

Hopes that WHO support will lend greater awareness

encephalitis international 2025 event
Experts convened in London to discuss the impact of the WHO’s new brief. From left: Dr Tom Solomon, Dr Benedict Michael, Dr Aline MB Matos, and Dr Nicoline Schiess.

For Professor Benedict Michael, a neurologist at the University of Liverpool, the new report “puts encephalitis on the map,” building on the advocacy successes in the past decade. While epilepsy and Parkinson’s have garnered more attention on the brain health front, the experts gathered at the Encephalitis International-WHO launch hope that the report will improve public health policies, including vaccine programs and vector control. 

“Encephalitis is just one example of why working together matters. From COVID-19 we learnt diseases do not respect borders, politics or ideologies. They affect us all,” said Dr Aline MB Matos.

Understanding the disease burden through improved surveillance, and improving patient care in rehabilitation and access to healthcare were also high on the priority list.

“Our recent research has shown that many of the interventions needed to improve diagnosis and treatment of encephalitis are not particularly expensive. A lot of it is about increasing surveillance and recognition of the condition, providing simple equipment for early diagnosis, and making sure the right treatments, many of which are very affordable, are available,” said Solomon.

The report points to several key factors that would reduce the burden of encephalitis, stating countries should prioritize relevant medicines for inclusion into national essential medications lists and standardized treatment protocols, include both autoimmune and infectious encephalitis and their treatments in publicly funded UHC packages, use and expand existing surveillance systems for forecasting demand and supply chains, and pair better availability and affordability of medicines with appropriate training and education of the health workforce to recognize and treat encephalitis in a timely manner. 

“There’s huge potential for this technical brief to have genuine global impact that’s transformative in the brain health agenda,” concluded Benedict.

Image Credits: Flickr: Florey Institute of Neuroscience & Mental Health, WHO, WHO, Encephalitis International.

Dr Tedros addresses the closing session.

Negotiators working to nail down the pandemic agreement have offered assurances that they can meet the May deadline – for the sake of global security and to restore faith in multilateralism.

Despite only five formal days of talks remaining in April, Pakistan’s Umair Khalid said his country believes there is enough time to clinch the agreement. 

“I don’t think any treaty is negotiated and agreed within a 9am-to-6pm, Monday to Friday setting. So you always have to put in some extra hours, and we have been doing that, and  we’ll continue to do that,” Khalid told a gathering of civil society groups meeting in Geneva during lunchtime on Friday.

“We will use March, we will use April, and we will use all the time that we have.”

India’s Dr Pradeep Khasnobis said that talks “are moving forward” and that “some of those very tough articles, at least have some kind of a landing zone”. 

Eswatini, speaking for the African region, Egypt and Sudan in the closing session, described the week’s talks as “constructive”.

“While we acknowledge concerns about the moderate pace, we are optimistic that the remaining issues, though critical, are manageable,” said Eswatini. 

“We must prepare to conclude our discussions in the five days allocated for the month of April, and we thank the Bureau for proposing additional discussions to address these gaps. We are ready to burn the midnight oils.”

The Philippines, speaking for a 11 diverse countries including Brazil, Canada and the UK, stressed the importance of reaching agreement to restore faith in multilateralism.

“Given the increased challenges facing this organisation, and multilateralism itself, there is a need to demonstrate that countries can indeed come together to solve common problems. We did this in May when we amended the International Health Regulations. This year, we need to adopt the WHO Pandemic Agreement,” said the Philippines, adding that member states managed to make “incremental improvements” to the text “by really listening to one another”.

“We have sat together in this room too many times over the last three years to not have a decent understanding of each other’s positions. We all have some sense of what the consensus text should look like,” id added.

“Let us finish what we have started. Adopting a meaningful Pandemic Agreement will be a win for all of us. The conclusion of the pandemic agereement in May will be a testimony to the world of our commitment to global health and of the continuing relevance of WHO in a time of major political challenges.”

Colombia’s Maria Tenorio Quintero told the civil society gathering that meeting the May deadline would take “extra effort”, and appealed to civil society to help raise public awareness about the positive impact that the agreement could have.

Norway’s Eirik Bakka stressed that the draft agreement “is not an empty shell, and there are important elements that are already agreed to bring it to the finishing line”.

‘Use every opportunity to find common ground’

Joining the closing session, Dr Tedros Adhanom Ghebreyessus, World Health Organization (WHO) Director-General, said that the 13th meeting of the Intergovernmental Negotiating Body (INB) had made progress – but “maybe not as much as you would have hoped”.

“As you move to finalize the pandemic agreement in time for the World Health Assembly, you have one week of formal negotiations left. 

“But you’re so close, closer than you think. You’re on the cusp of making history. This agreement should not fail on a word; it should not fail on a comma and it should not fail on a percentage.

 “History will not forgive us if we fail to deliver on the mandate the world needs, and a sign that multilateralism still works. Reaching a WHO pandemic agreement in the current geopolitical environment is a sign of hope.”

Tedros concluded with two messages: “We believe you can do it” and “Use every opportunity during the intercessional period to come closer together towards finding common ground.”

Civil society anxiety

Nina Jamal of Four Paws and KEI’s Jamie Love.

Civil society organisations following the pandemic agreement negotiations over the past three years are anxious that it won’t be completed by May – and that impetus for the initiative will fizzle and further undermine multilateralism.

A sombre group of over 75 people met in person and online in Geneva over lunch on Friday to express frustration at the slow pace of talks over the past five days. 

With only five official negotiating days remaining – 7-11 April – many complex parts of the agreement are not agreed. The group also raised concerns about provisions being watered down of provisions, particularly on technology transfer and intellectual property, and the absence of clauses on prevention.

Knowledge Ecology International’s Jamie Love expressed disappointment over “the lowering of the ambitions on the initial versions of the text and watering down of provisions”.

He also raised that it may suit some parties, particularly the European Union, not to have an  agreement in May given the “rise of the anti vaxxers and right-wing populism”.

Ellen ‘t Hoen of Medicines Law and Policy described reaching agreement as “crucial now in the current political context and the huge global health crisis caused by the United States withdrawal of aid and European countries slashing their aid budgets”.

“This makes the need for having a signal that multilateralism still works even more important than in the earlier days of the pandemic. This total lack of international solidarity is of huge concern.”

Meanwhile, Four Paws’ Nina Jamal said member states seemed to accept the importance of the agreement for multilateralism

However, Jamal added that pandemic prevention offers the best chance to protect people in countries with weak health systems.

“This is the deepest level of equity that we can achieve. And we are disappointed because a lot of countries who  support prevention and are taking action nationally on prevention with a One Health approach are not being vocal in the negotiations because they think if they talk about prevention, they’re disadvantaging their negotiating position for medical countermeasures, preparedness and response.”

Health professionals – icluding those working on outbreak investigation, maternal mortality, and vector-borne disease – across HHS’s 13 divisions saw mass layoffs as the Trump administration attempts to reduce the size of the federal workforce.

The large-scale government firings have now targeted thousands of probationary employees at the Department of Health and Human Services (HHS), wiping out the ranks of young and up-and-coming scientists from the nation’s leading health and research agencies as well as the more senior staff who had advanced to new positions. 

Although it is unclear how many workers the Trump administration plans to cut, dismissing scientists on probation who do not yet enjoy the same job protections in the civil service system, offer an easy target for termination. 

“It’s using a machete instead of a surgical knife,” Dr Michael Osterholm, an epidemiologist and director of the University of Minnesota’s Center for Infectious Disease Research and Policy (CIDRAP), told Health Policy Watch in an interview. 

Contrary to popular perceptions about government bloat, he noted that the federal government workforce is slightly smaller today than 50 years ago in the 1970s despite a 68% growth in the US population. The number of government contractors, however, has doubled. 

Dismissal emails continue to be sent out to the 13 operating divisions under HHS citing “poor performance,” even though many had just received “outstanding” job reviews. 

Last Thursday, the Office of Personnel Management (OPM) directed all federal agencies to terminate those in their probationary period.

Federal employees remain on probation for one to two years after hiring, depending on the position and agency, many of which are highly competitive. Probationary status lacks the benefits of permanent employment, making them easier to remove. Those in probation include recent hires and career staffers who began new positions or were promoted.

Public health experts targeted

“The probationary period is a continuation of the job application process, not an entitlement for permanent employment. Agencies are taking independent action in light of the recent hiring freeze and in support of the President’s broader efforts to restructure and streamline the federal government to better serve the American people at the highest possible standard,” an OPM spokesperson said in a statement, and as reported by The Hill.

The move is a reversal from an OPM directive just days earlier, when agencies were told to remove probationary employees only if they were poor performers.

The exact number of health professionals has not been released, but the New York Times reports that 1,200 NIH employees were dismissed, and National Public Radio reports that 750 Centers for Disease Control and Prevention (CDC) experts received notice of their removal. 

FDA, CMS, CDC see lay-offs, other divisions spared

Indian health service flags
The Indian Health Service (IHS) serves 2.8 million American Indians and Alaskan Natives. The order to fire over 1,000 IHS employees was rescinded.

Emails firing probationary employees were sent to the Food and Drug Administration (FDA), Centers for Medicare and Medicaid Services (CMS), and the Administration for Strategic Preparedness and Response (ASPR). Staff affected include researchers investigating emerging diseases, such as rabies, dengue, oropouche, and others, reports the Washington Post, in what it called the “Valentine’s Day massacre” of federal layoffs.

Also nixed is the CDC’s Public Health Associate’s Program, which places trainees into local, state, and tribal public health agencies in an effort to alleviate workforce shortages.

Initially, over 1,000 Indian Health Service (IHS) employees received notice of their removal last Friday, reported Native News Online. The IHS provides care to 2.8 million indigenous Americans and Alaska Natives, who suffer disproportionately high rates of diabetes, cancer, COVID-19, and other illnesses.

But later in the evening, the firings were rescinded. The newly confirmed HHS Secretary, Robert F Kennedy Jr, told Native News that he acknowledged that IHS “was chronically understaffed and underfunded.” 

At the CDC, similar turmoil and mixed messaging meant that the Epidemic Intelligence Service (EIS) was potentially facing disbanding last Friday. But the quick public outcry meant that the nation’s deployable “disease detectives” were spared. 

“Efficiency is more than cutting dollars— it’s about improving processes, strengthening infrastructure, and ensuring sustainability – making every dollar work to its fullest potential for Americans,” said Dr Katelyn Jetelina, an epidemiologist and founder of Your Local Epidemiologist. “Prevention and early intervention are an investment – often paying 2-60x in return by reducing healthcare costs, improving workforce productivity, and making communities safer.

“There’s room for improvement, but if we want to lose weight, let’s not cut off our legs.”

Even so, this is less than the 10% cuts promised by the administration.

The firings were not unique to public health operations – air traffic controllers at the FAA, TSA agents, and the National Science Foundation were also affected. Some experts have been asked to come back – notably nuclear safety officers – after the new administration realized their work is vital to government operations. The Trump administration is reportedly having trouble reaching these experts.

On Thursday, a federal judge denied a lawsuit filed by unions representing federal workers that OPM is overstepping its authority. The judge said he did not have jurisdiction over the matter as it should be decided by the Federal Labor Relations Authority.

For public health experts, the indiscriminate firings are a matter of American public health security. 

“Whether it be at FDA, CDC, NIH, I think those three agencies in particular are going to be severely challenged over the weeks and months ahead,” said Osterholm, in an interview with Health Policy Watch. 

“I don’t think we have any idea yet of just what the breadth of those cuts are going to be or how it happens.”

Dr Georges Benjamin, executive director of the American Public Health Association, echoed this sentiment in a statement to NPR, calling the cuts at the CDC “indiscriminate, poorly-thought-out layoffs” that would be “very destructive to the core infrastructure of public health.”

Bird flu response in flux

Officials trying to contain bird flu were among those fired over the weekend. USDA says it is “working swiftly to rectify the situation.”

The US Department of Agriculture (USDA), which trying to contain the ongoing avian influenza epidemic, has been trying to reach the experts it “accidentally” fired over the weekend.

“Although several positions supporting [bird flu efforts] were notified of their terminations over the weekend, we are working to swiftly rectify the situation and rescind those letters,” a USDA spokesperson said in a statement. 

“USDA’s Food Safety and Inspection Service frontline positions are considered public safety positions, and we are continuing to hire the workforce necessary to ensure the safety and adequate supply of food to fulfill our statutory mission.”

Lawmakers on both sides of the aisle have expressed concerns over the firings, which are part of the Department of Government Efficiency (DOGE)’s attempts to cut back on government spending.

“They need to be more cautious,” Rep. Don Bacon (R-NE), a member of the Agriculture Committee, told NBC News in a statement about the DOGE team. 

“There’s an old saying, ‘Measure twice, cut once.’ Well, they are measuring once and having to cut twice. Some of this stuff they’re going to have to return back. I just wish they’d make a better decision up front.”

Cuts are ‘arbitrary’ 

The public health activities of HHS span overseeing food and drug safety, responding to and containing disease outbreaks, and providing direct healthcare to hundreds of thousands of Americans. 

But critics point to the growing US deficit, which has grown to $1.3 trillion since 2001, as a compelling reason for DOGE to continue cutting the federal workforce. 

DOGE “senior advisor,” billionaire Elon Musk, has said that his goal is to cut federal spending by $2 trillion, out of a $6.75 trillion annual budget in the latest fiscal year. The entrepreneur has made unsubstantiated claims that he has already saved $8 billion.

In reality, the federal workforce has not grown in proportion to the US population. “I understand the need to address the growing deficit problem,” said Osterholm. “But…we should be looking to find ways to strategically and tactically [reduce the deficit], and not just arbitrarily. 

“There’s no real rhyme or reason as to who you’re cutting or why.”

RFK commission to ‘scrutinize childhood vaccine schedules’

Robert F Kennedy Jr (RFK Jr) day 2 confirmation hearing
Amid mass lay-offs of federal health workers, HHS Secretary Robert F Kennedy Jr has set up a commission to look at childhood vaccines.

Efforts to downsize the nation’s public health workforce come just as new HHS Secretary Robert F  Kennedy Jr, said he was moving forward with plans to create a presidential commission to scrutinize childhood vaccine schedules. 

That commission, part of the overall effort to “Make America Healthy Again” will likely target CDC’s Advisory Committee on Immunization Practices, which sets influential vaccine recommendations. 

“Nothing is going to be off limits,” Kennedy said in an HHS meeting that was reported by several news outlets. 

“Some of the possible factors we will investigate were formally taboo or insufficiently scrutinized. Childhood vaccine schedule, electromagnetic radiation, glyphosate, other pesticides, ultra-processed foods, artificial food allergies, SSRI [antidepressants] and other psychiatric drugs, PFAS, PFOA, microplastics — nothing is going to be off limits,” Kennedy said on Tuesday. And late Thursday, HHS ordered CDC to halt some vaccine advertisements to emphasize “informed consent.”

His moves come despite promises by the HHS secretary after his confirmation that employees who are “involved in good science” or who “care about public health” have “nothing to worry about.”

 

Image Credits: CDC, IHS, Charlotte Kesl/ World Bank.

People flee Goma during the latest clashes

 The eastern part of the Democratic Republic of Congo (DRC) particularly around Goma and Bukavu, may become a hotspot for disease transmission following renewed conflict and the freeze in aid from the United States, warned Dr Jean Kaseya, Director General of the Africa Centres for Disease Control and Prevention (Africa CDC).

Amid fighting when M23 rebels recently seized the two towns from DRC forces, over 400 mpox patients fled from health facilities, while outbreaks of cholera and measles are also affecting the region.

Over a million displaced people living in Goma and over 150,000 in Bukavu are particularly vulnerable to disease.

“This can be the entry point for a new pandemic,” warned Kaseya, adding that none of the regions affected by insecurity are reporting on diseases and laboratory testing has been disrupted by the United States freeze on foreign funds.

“In regions like South Kivu and North Kivu, we don’t have information, either because of insecurity or the pause in the US government funding, because the mechanism that we had in place in terms of sample referral was based on US funding provided to DRC,” Kaseya told a media briefing on Thursday. 

The DRC’s mpox response is affected by conflict and lack of funds.

“The combination of insecurity, lack of funding and lack of medical countermeasures, [means] we are playing with fire.”

Earlier in the week, Grégoire Mateso Mbuta, president of the DRC Red Cross said that “the humanitarian situation is dire in Bukavu and Goma.

“In Goma, the morgues and hospitals are overwhelmed. Around 190 DRC Red Cross volunteers and a team of coordinators are working tirelessly to recover the bodies left in the streets, take measures to prevent epidemics and give the victims a dignified burial. In the face of so much need, more help must be provided urgently, ” he added in a joint statement released by the International Committee of the Red Cross, the International Federation of the Red Cross and the Red Cross Society in the DRC.

New fund for epidemics

Dr Jean Kaseya

The African Union finally gave the go-ahead for an African Epidemic Fund to raise money to address continental disease outbreaks at its meeting last week, which is crucial in the wake of the US  withdrawal of foreign funding.

The fund will be administered by Africa CDC and facilitate a flexible and speedy response to outbreaks, according to Kaseya.

“We can receive funding without any limitation, without any bureaucracy, to use that to support African countries to prepare and to respond to outbreaks,” said Kaseya.

Africa CDC will provide the secretariat for the fund, which will be guided by a board.

Aside from the DRC’s mpox outbreak, continental malaria, tuberculosis and HIV efforts, have been affected by the US aid freeze. 

The US under President Joe Biden pledged $500 million to assist the continent with mpox and other outbreaks with $385 million committed. 

Kaseya said that Africa CDC was negotiating to “see this commitment become real money”, but that talks were ongoing. 

Since the funds freeze announced on 20 January when Donald Trump assumed office, China and South Korea have pledged $4 million and Morocco has also pledged $2 million –  but this makes up a teeny percentage of US aid to the continent. 

Kaseya said that Africa CDC had engaged with US officials immediately after Trump announced the freeze a month ago, and claimed some credit securing the US waiver on life-saving humanitarian expenditure.

However, despite the waiver, numerous health projects are still in limbo as they wait for official waiver letters.

In addition, “all HIV prevention activities were excluded from the waiver, except for those aimed at preventing mother-to-child transmission”, according to amFar this week. 

“To date, few implementers have been approved to restart services under the waiver, leaving all activities, including treatment, still paused.” 

Mpox tech transfer deal with African company

While there are no accurate mpox figures from the DRC, the epidemic is growing in Uganda, Congo Brazzaville and Zambia, which has shown a huge jump in figures from 16 to 700 cases.

However, in a glimmer of good news mpox vaccine manufacturer Bavaria Nordic has “95%” concluded a technology transfer deal with an African company to enable the vaccine to be produced on the continent.

This transfer will be a “fill and finish” deal rather than the more comprehensive drug substance transfer.

Dr Ngashi Ngongo, head of Africa CDC’s Incident Management Support Team, said he was working on creating demand for the mpox vaccine including the creation of a continental stockpile to ensure that countries would buy the locally manufactured vaccine.

Image Credits: Ley Uwera/ International Committe of the Red Cross.

In October 2024, the final phase of the polio vaccine campaign in Gaza’s northernmost neighborhoods was never fully completed due to intense fighting. Now, after discovering more poliovirus in Gaza wasteater, WHO and UNICEF are launching a third vaccination round.

A third mass polio vaccination campaign will be carried out next week in the embattled Gaza Strip, following the further detection of poliovirus in wastewater samples, WHO and UNICEF said in a surprise, joint announcement on Wednesday.

“This campaign follows the recent detection of poliovirus in wastewater samples in Gaza, signaling ongoing circulation in the environment, putting children at risk,” the agencies declared.

The new round follows two successful vaccine rounds last autumn, including one carried out during a brief pause from the height of bitter fighting in northern Gaza.  But while those succeeded in reaching over 95% of children 10 and under who were targeted, it apparently was not enough to wipe out the virus entirely. During the second round, in October, WHO also warned that the inability of vaccine teams to reach children in the northernmost neighborhoods of Gaza such as Jabalia, to which Israel had blocked healthworker access while heavy fighting raged, could create future pockets of vulnerability.

“Pockets of individuals with low or no immunity provide the virus an opportunity to continue spreading and potentially cause disease,” WHO and UNICEF said in the statement. ” The current environment in Gaza, including overcrowding in shelters and severely damaged water, sanitation, and hygiene infrastructure, which facilitates fecal-oral transmission, create ideal conditions for further spread of poliovirus. Extensive population movement consequent to the current ceasefire is likely to exacerbate the spread of poliovirus infection.”

Most of Gaza’s sewage infrastructure – along with homes, schools and other infrastructure, have been destroyed during Israel’s invasion of Gaza and 16 months of fighting with Hamas that followed the bloody Hamas raids 7 October into Israeli communities near the Gaza enclave, that led to 1200 deaths and the capture of some 250 hostages. Over 46,000 Gaza Palestinians have been killed by Israel in the ensuing war.

“No additional polio cases have been reported since a ten-month-old child was paralyzed in August 2024,” the agencies said.  “But the new environmental samples from Deir al Balah and Khan Younis, collected in December 2024 and January 2025, confirm poliovirus transmission. The strain detected is genetically linked to the poliovirus detected in the Gaza Strip in July 2024.”

Cease fire creates better access to areas missed

Health workers leaving Kamal Adwan Hospital in December after months of fierce fighting in Gaza’s northern communities – which also impeded polio vaccination.

The six week Israel-Hamas ceasefire, that began on 19 January, has also created a much better opportunity for vaccination teams to reach areas that were missed during the October round.

“In 2024, health workers faced significant challenges accessing certain areas of central, north and south Gaza, which required special coordination to enter during the conflict,” the WHO/UNICEF statement noted. “In inaccessible areas such as Jabalia, Beit Lahiya, and Beit Hanoun where humanitarian pauses for the vaccination campaign were not assured, approximately 7,000 children missed vaccination during the second round. The recent ceasefire means health workers have considerably better access now. ”

It’s also clear that the UN health agencies are moving quickly in order to seize the moment of relative calm. The first six-week ceasefire period ends next weekend.

And it almost fell apart last week when Hamas momentarily said it was pausing release of the next three Israeli hostages – before finally going ahead with their release on Saturday, 15 February, as planned.  This Saturday, Hamas has even speeded up the pace, saying it will release the last of the six living Israeli hostages set to be released in this phase of the deal – instead of the three to which it was committed by the agreement.  The bodies of eight deceased Israeli hostages are also to be released before the initial six-week period of calm ends on March 1 next weekend.  Although the two parties have pledged to preserve the peace as long as negotiations for a second phase are continuing, those talks are expected to be even more complex than the first stage agreement, which took months to reach.

All in all, some 33 Israeli hostages are due to be released in the six-week cease-fire. In exchange for each Israeli released, Israel has been releasing some 30–50 Palestinians held in Israeli jails. Israel has also pulled its forces back from the Netzarim corridor that blocked Palestinian movement from southern to northern Gaza, last autumn, as well as from Gaza’s Rafah cross with Egypt, and allowed a surge of humanitarian aid into Gaza.

Doron Steinbrecher, among the first three, of 33 Israeli hostages to be released during the current cease-fire deal, was turned over to the Red Cross on Sunday, January 19.

However, big question marks remain over the future of the present truce.  After the the next pending hostage releases are completed, Hamas will continue to hold over 58 Israelis, young civilian men and soldiers, less than half of whom may really be alive.  Those remaining hostages will only be released as part of a permanent ceasefire deal. At the same time, Israel’s government has said that it won’t agree to a permanent arrangement that leaves Hamas in power in Gaza – although neither Israel nor Arab mediators have so far come up with an alternative governance plan.

And while there is wide support among the Israeli public for the continuation of the ceasefire so that all hostages are released, government hardliners are pressing for a return to war. To complicate negotiations on a second phase even more, United States President Donald Trump has shocked and alienated both Palestinians and the Arab world with his recent declarations that Gazans should be evacuated so that the area can be turned into a “Riviera” under US control – something that would be illegal under international law.

Against this very uncertain future, next week’s polio campaign will unroll. WHO said all Gaza children under 10 years of age will be targeted with a second, or even a third, polio vaccine:  “The upcoming vaccination campaign aims to reach all children under 10 years of age, including those previously missed, to close immunity gaps and end the outbreak. The use of the oral polio vaccine will help end this outbreak by preventing the spread of the virus. An additional polio vaccination round is planned to be implemented in April.”

It added that “there is no maximum number of times a child should be vaccinated. Each dose gives additional protection which is needed during an active polio outbreak.”

Image Credits: WHO, Middle East Eye , @nabilajamal.

Callie Weber, Dr Jackson Otieno, Amref’s Dr Mercy Mwangangi and Reach52’s Ben Kamarck

KIGALI, Rwanda – Confronted by a huge and growing burden of non-communicable diseases (NCDs), governments worldwide are under pressure to devote more of their domestic budgets to these illnesses.

Patients carry the burden of both the diseases and an estimated 60% of the cost of treating these, which include cardiovascular disease, cancer and diabetes.

Yet the sheer range of diseases, the high cost of NCD medicines and treatment and an apparent lack of donor interest in NCDs are daunting obstacles. (Only around 3% of official development assistance goes to NCDs.)

Ahead of the United Nations High-Level Meeting (HLM) on NCDs in September, NCD advocates want governments to commit to concrete implementation targets in whatever declaration is adopted.

Civil society organisations meeting at the NCD Alliance Forum in Kigali last week discussed various options for governments to increase domestic resources for NCDs, which are responsible for almost three-quarters deaths each year. 

Despite Africa’s youthful population, 37% of deaths on the continent are due to NCDs – and this is growing annually. Cardiovascular diseases such as strokes and heart attacks have overtaken tuberculosis and respiratory infections as the biggest killer on the continent.

Various possibilities exist for bolstering countries’ domestic resources for NCDs, including excise taxes, pooled procurement with other countries to bring down medicine prices and incentives to encourage the private sector to invest in NCDs.

Excise taxes are a win-win

If the excise taxes currently imposed on tobacco, alcohol and sugary drinks are increased by 50%, this would save 50 million lives over the next 50 years, said Vital Strategies CEO Mary-Ann Etiebet, quoting research from the Task Force on Fiscal Policy for Health.

Aside from deterring people from consuming these unhealthy products, these taxes could raise over $3.5 trillion in five years which could be ploughed back into NCD prevention, treatment and care.

Many governments have not embraced these taxes thanks to intense lobbying by the tobacco, alcohol and junk food companies.

Removing government subsidies for harmful products such as oil or sugar can also improve the overall pool of financing available for health, said Kimberly Green, PATH’s global director of primary health care and part of the Coalition for NCDs Access to Medicinces and Products (Coalition4NCDs).

But this too faces huge industry pushback.

Forecasting demand

For Green, “one of the fundamental challenges is demand forecasting”. Governments need to identify their priority NCDs and project how many people will be affected over the next five to 10 years.

“Without this, it is impossible to know how much medicine they will need. This is a fundamental gap yet demand forecasting has been very well done in HIV, TB and malaria,” said Green.

The Coalition4NCDs has developed a forecasting tool that it has shared with some parliamentarians to enable them to increase the budget for NCDs

But Rwanda’s Dr Evode Nyibizi warned that accurate data alone is not enough.

His country’s health system is fully digitised, so financial decisions are based on data fed from all tiers of the health system.

“In 2023, we were only utilising around 10% of the data that we collected on daily basis. So we established the National Health Intelligence Centre, which is helping us to draw insights from the data that we collect,” said Nyibizi, who heads the centre.

“The centre tells you what the problems are and where you need to invest your money,” Nyibizi explained.

Particularly in light of the global health financing crisis experienced by the withdrawal of United States aid, many countries need to reprioritizing where “the small amount of money left goes”, he added.

PATH’s Kimberly Green and MedAccess’s Mayank Anand

Creating demand

But even before demand forecasting, Ben Kamark’s organisation, Reach52, works to generate demand for essential health products to reach the 52% of the world who don’t have access to these.

“Out-of-pocket markets have peculiar market dynamics. They get stuck in a vicious cycle. Every distributor, every seller of pharmaceutical products, is incentivized to sell less products at a higher price,” explained Kamarck. 

“So they come into the market with a higher price, expecting a lower demand. But a higher price leads to lower demand, which also importantly, leads to lack of investment.”

Insulin is an example of a product for which the price is higher than it should be because demand is lower than it should be, he explained.

“Then the market doesn’t move. We believe that the only way to actually intervene in an out-of-pocket market is to be a market participant.”

And it takes a lot of risks. Reach52 launch medicines at prices that “would make sense in high volumes, even when there aren’t high volumes”, said Kamarck. 

They register products “that no one’s asking for and no one’s wanted, because we know there’s a need for them”.

Then Reach52 runs “hyper-targeted public health interventions and healthcare provider engagement” to create demand and drive sales of essential medicines.

“That’s a hard choice to make for a lot of private sector companies,” admitted Kamarck.

Reach52 runs “hyper-targeted public health interventions and healthcare provider engagement” to create demand and drive sales of essential medicines.

Reducing risks

Mayank Anand works for MedAccess, a social finance company established in 2017 with the support of donors, health advocacy organisations and pharmaceutical companies. 

Its aim is to reduce the risks in the NCD treatment supply chain for suppliers and procurers through volume guarantees, procurement guarantees, and concessionary loans.

“We’ve has done 11 guarantees so far across areas such as TB, HIV, malaria, syphilis, and COVID-19 with range of partners such as the Clinton Health Access Initiative (CHAI),” he explained.

“A volume guarantee is a backstop agreement between ourselves and supplier where we assure sales volumes over a period of two to six years in return for the supplier bringing the price down to an affordable price, but also making commitments to accelerate registration in markets,” said Anand.

The 11 deals done so far has enabled half a billion people to get access to medicines.

Another public-private partnership is the Financing Accelerator Network for NCDs (FAN), a new initiative started by Access Accelerated, the World Bank, and Results for Development (R4D), aimed at building sustainable health financing systems for NCDs.

Leadership is at the centre

Amref Health Africa’s Dr Mercy Mwangangi injected come realism into discussions by pointing out that almost 80% of the $9.8 trillion spent annually on health is spent in the global North.

In Kenya, where she is based, the per capita expenditure is $90 whereas in the US, it is $14,000.

“How do we ensure that drugs are available to the American who is spending $14,000 are also available to the Kenyan, where there’s a $90 spent every year?” she asks.

Aside from lack of finances, health systems also have to be ready to roll out medicines should innovative finances make them available, she adds.

Can a country screen for cancer? Does it have a national registry of the burden of disease?  Do supply chains work so that citizens can access care? Are the legal and regulatory frameworks amendable to access to medicines? 

To spell out the challenges, Mwangangi gave a rundown of Amref’s engagements with pharmaceutical company Roche to enable Kenyans to get access to the breast cancer drug, Herceptin.

“From the initiation of those conversations to having patients access these commodities took about two years of back-to-back conversations with government players, procuring agencies and with repayment systems,” she said.

Despite this energy investment, the programme has stalled because facilities are not able to pay the procuring agency for the medicine that they have been issued with.

“Leadership and governance is at the centre of innovative financing,” stressed Mwangangi.

Image Credits: Reach52.